Correlation Between Gmo Global and Allianzgi Health

Can any of the company-specific risk be diversified away by investing in both Gmo Global and Allianzgi Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gmo Global and Allianzgi Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gmo Global Equity and Allianzgi Health Sciences, you can compare the effects of market volatilities on Gmo Global and Allianzgi Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gmo Global with a short position of Allianzgi Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gmo Global and Allianzgi Health.

Diversification Opportunities for Gmo Global and Allianzgi Health

0.72

Correlation Coefficient

Gmo Global  Allianzgi Health

Poor diversification

The 3 months correlation between Gmo and Allianzgi is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Gmo Global Equity and Allianzgi Health Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allianzgi Health Sciences and Gmo Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gmo Global Equity are associated (or correlated) with Allianzgi Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allianzgi Health Sciences has no effect on the direction of Gmo Global i.e., Gmo Global and Allianzgi Health go up and down completely randomly.

Pair Corralation between Gmo Global and Allianzgi Health

Assuming the 90 days horizon Gmo Global Equity is expected to under-perform the Allianzgi Health. In addition to that, Gmo Global is 1.23 times more volatile than Allianzgi Health Sciences. It trades about -0.14 of its total potential returns per unit of risk. Allianzgi Health Sciences is currently generating about -0.14 per unit of volatility. If you would invest  3,012  in Allianzgi Health Sciences on October 15, 2024 and sell it today you would lose (207.00) from holding Allianzgi Health Sciences or give up 6.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Gmo Global Equity  vs.  Allianzgi Health Sciences

Gmo Global Equity

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gmo Global Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Allianzgi Health Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allianzgi Health Sciences has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Gmo Global and Allianzgi Health

The main advantage of trading using opposite Gmo Global and Allianzgi Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gmo Global position performs unexpectedly, Allianzgi Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allianzgi Health will offset losses from the drop in Allianzgi Health's long position.

The idea behind Gmo Global Equity and Allianzgi Health Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.